September 3rd 2024
The updated COVID-19 vaccine targets the currently circulating Omicron variant JN.1 strain of SARS-CoV-2.
August 23rd 2024
Topics include declining vaccine coverage among kindergarten-aged children and key changes in recommendations for adult vaccination.
August 22nd 2024
The updated COVID-19 vaccines will include a monovalent component corresponding to KP.2, a strain of the Omicron variant of SARS-CoV-2.
July 9th 2024
A new study shows that higher vaccination rates were associated with a decrease in the prevalence of parent-reported asthma symptoms in children.
June 28th 2024
Individuals 6 months and older should receive updated COVID-19 and influenza vaccines for the 2024-2025 respiratory virus season, the agency recommended.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of July 27, 2022
Data from the CDC on US vaccination and booster shot rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
COVID-19 Update: US Vaccinations, Booster Doses, & Global Data as of July 26, 2022
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Monkeypox Virus Questions & Answers for Family Physicians: Highlights from an AAFP Conversation
A public health expert sat down with the American Academy of Family Physicians to answer some common questions about the virus. Get the topline, here.
Monkeypox: WHO Declares Public Health Emergency of International Concern
The WHO's highest level of alert indicates the organization's belief that the now multicountry monkeypox outbreak requires a coordinated international response.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of July 22, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of July 20, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of July 19, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of July 18, 2022
Refugee Immunization Requirements: A Pop Quiz
Refresh your memory on refugee immunization recommendations with a 3-question quiz based on a patient scenario.
New MMR Vaccine Ready for Fall: How Will it Be Different?
The GSK MMR vaccine Priorix is the first new MMR shot to be available since the Merck immunization was approved in 1971. Similar? Different? Find out.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of July 13, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of July 12, 2022
Newer Omicron Subvariants Evade Neutralizing Antibodies from Vaccination and Prior Infection, Says New Research
Findings showed neutralizing antibody responses to BA.4 and BA.5 subvariants were approximately 20-fold lower than to the original WA1/2020 strain.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of July 6, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 30, 2022
FDA Recommends COVID-19 Booster Doses Optimized for Omicron Variant
The FDA recommended on Thursday the inclusion of a SARS-CoV-2 Omicron component in COVID-19 vaccine booster doses.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 28, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 27, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 23, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 22, 2022
Merck & Co 21-valent Pneumococcal Conjugate Vaccine Ready for Phase III
The 21-valent pneumococcal conjugate vaccine targets 85% of invasive pneumococcal disease in adults aged ≥65 years; 8 serotypes are exclusive to this vaccine, says Merck.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 21, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 17, 2022
FDA Authorizes Pfizer and Moderna COVID-19 Vaccines for Children 6 Months and Up
The FDA authorized emergency use of Moderna and Pfizer-BioNTech's COVID-19 vaccines for use in children as young as 6 months old.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 16, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 15, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 14, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 13, 2022
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of June 9, 2022
FDA Advisory Committee Recommends Emergency Use Authorization of Novavax COVID-19 Vaccine for Persons Aged 18 Years and Older
If EUA is granted, the Novavax COVID-19 vaccine would be the first protein-based COVID-19 vaccine available in the US.